1. Home
  2. LEE vs ADAG Comparison

LEE vs ADAG Comparison

Compare LEE & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEE
  • ADAG
  • Stock Information
  • Founded
  • LEE 1890
  • ADAG 2011
  • Country
  • LEE United States
  • ADAG China
  • Employees
  • LEE N/A
  • ADAG N/A
  • Industry
  • LEE Newspapers/Magazines
  • ADAG Biotechnology: Pharmaceutical Preparations
  • Sector
  • LEE Consumer Discretionary
  • ADAG Health Care
  • Exchange
  • LEE Nasdaq
  • ADAG Nasdaq
  • Market Cap
  • LEE 90.6M
  • ADAG 81.9M
  • IPO Year
  • LEE N/A
  • ADAG 2021
  • Fundamental
  • Price
  • LEE $11.46
  • ADAG $1.76
  • Analyst Decision
  • LEE
  • ADAG Strong Buy
  • Analyst Count
  • LEE 0
  • ADAG 1
  • Target Price
  • LEE N/A
  • ADAG $8.00
  • AVG Volume (30 Days)
  • LEE 23.1K
  • ADAG 153.3K
  • Earning Date
  • LEE 02-06-2025
  • ADAG 03-09-2025
  • Dividend Yield
  • LEE N/A
  • ADAG N/A
  • EPS Growth
  • LEE N/A
  • ADAG N/A
  • EPS
  • LEE N/A
  • ADAG N/A
  • Revenue
  • LEE $600,264,000.00
  • ADAG $815,746.00
  • Revenue This Year
  • LEE N/A
  • ADAG N/A
  • Revenue Next Year
  • LEE N/A
  • ADAG $2.70
  • P/E Ratio
  • LEE N/A
  • ADAG N/A
  • Revenue Growth
  • LEE N/A
  • ADAG N/A
  • 52 Week Low
  • LEE $7.57
  • ADAG $1.64
  • 52 Week High
  • LEE $19.63
  • ADAG $3.65
  • Technical
  • Relative Strength Index (RSI)
  • LEE 32.32
  • ADAG 42.36
  • Support Level
  • LEE $11.40
  • ADAG $1.64
  • Resistance Level
  • LEE $13.69
  • ADAG $1.95
  • Average True Range (ATR)
  • LEE 0.80
  • ADAG 0.10
  • MACD
  • LEE -0.10
  • ADAG 0.00
  • Stochastic Oscillator
  • LEE 6.58
  • ADAG 37.50

About LEE Lee Enterprises Incorporated

Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.

About ADAG Adagene Inc.

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.

Share on Social Networks: